In melanoma and breast cancer, CD276 has been reported to promote metastasis and chemoresistance through regulating JAK2/STAT3 signaling pathways and promoting the expression of cytokines and other metastasis-associated genes [16, 17]. This evidence concerns the gene STAT3 and breast cancer.